CDKN1B and esophageal squamous cell carcinoma: Treatment of ESCC cells with Trichostatin A (TSA), an HDACI, inhibited proliferation of ESCC cells and arrested the cells in the G1 phase by upregulating p21Cip1 and p27Kip1 cell cycle inhibitors [146].